Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 7
2003 6
2004 7
2005 8
2006 7
2007 11
2008 12
2009 7
2010 9
2011 11
2012 3
2013 3
2014 2
2015 2
2016 1
2017 6
2018 5
2019 1
2020 4
2021 3
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

108 results
Results by year
Filters applied: . Clear all
Page 1
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.
Gaziano JM, Brotons C, Coppolecchia R, Cricelli C, Darius H, Gorelick PB, Howard G, Pearson TA, Rothwell PM, Ruilope LM, Tendera M, Tognoni G; ARRIVE Executive Committee. Gaziano JM, et al. Among authors: pearson ta. Lancet. 2018 Sep 22;392(10152):1036-1046. doi: 10.1016/S0140-6736(18)31924-X. Epub 2018 Aug 26. Lancet. 2018. PMID: 30158069 Free PMC article. Clinical Trial.
Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.
Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F; Centers for Disease Control and Prevention; American Heart Association. Pearson TA, et al. Circulation. 2003 Jan 28;107(3):499-511. doi: 10.1161/01.cir.0000052939.59093.45. Circulation. 2003. PMID: 12551878 No abstract available.
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.
Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Flather MD, Haffner SM, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Brennan DM, Fabry-Ribaudo L, Booth J, Topol EJ; CHARISMA Investigators. Bhatt DL, et al. Among authors: pearson ta. N Engl J Med. 2006 Apr 20;354(16):1706-17. doi: 10.1056/NEJMoa060989. Epub 2006 Mar 12. N Engl J Med. 2006. PMID: 16531616 Free article. Clinical Trial.
Somatic Mutations in "Benign" Disease.
Dasa O, Pearson TA. Dasa O, et al. Among authors: pearson ta. N Engl J Med. 2021 Sep 9;385(11):e34. doi: 10.1056/NEJMc2110545. N Engl J Med. 2021. PMID: 34496189 No abstract available.
In the clinic. Dyslipidemia.
Kopin LA, Pearson TA. Kopin LA, et al. Among authors: pearson ta. Ann Intern Med. 2007 Sep 4;147(5):ITC9-1-ITC9-16. doi: 10.7326/0003-4819-147-5-200709040-01009. Ann Intern Med. 2007. PMID: 17785482 Review. No abstract available.
Lipoprotein(a): implications for clinical practice.
Block RC, Pearson TA. Block RC, et al. Among authors: pearson ta. Curr Atheroscler Rep. 2005 Sep;7(5):327-9. doi: 10.1007/s11883-005-0041-1. Curr Atheroscler Rep. 2005. PMID: 16105473 Review. No abstract available.
108 results